Recently developed techniques of culturing human tissues permit the in vitro recovery of progenitor cells and the study of factors that regulate the growth of these cells. We applied this technique to benign and malignant breast tissues to determine how their ability to grow in agar changes as transformation occurs and as tumours progress. We also measured the responsiveness of the clonogenic cells from these tissues to a combination of four growth factors. We found that there was a continuing progression of increasing proliferation in agar from benign through primary carcinoma to metastases. We also found that the clonogenic cells of tissues from all stages retained their responsiveness to the tested growth factors and that the degree of their hormonal responsiveness remained similar to that of the parent tissue.
In common with their parent tissues, tumours are composed of stem cells and of their progenitor cells. Unlike the parent tissues, however, the proliferative activity of tumour progenitor cells is regulated by growth factors unique to tumours Dickson et al., 1986) . A contributory role of the growth regulators of the parent tissue is not certain. Techniques to recover the clonogenic tumour cell populations (the in vitro counterparts of stem cell progenitors) have recently been developed (Hamburger & Salmon, 1977a, b; Courtenay et al., 1978; Kinball et al., 1978) . Since the culturing of these cells provides a tool to study tissue growth regulation, we used the technique to define the colony forming ability and the proliferative response to some selected hormones, of benign and malignant breast tissues. Normal breast tissue was obtained from 9 women, 7 of whom underwent a reduction mammoplasty and 2 a modified radical mastectomy. Four of these women had in the past been treated for stages I Remaining aggregates of cells were removed by passing the suspension sequentially through 18-, 22-, and 25-gauge needles. A Coulter counter (Coulter Electronics, Hialeah, FL) was used, and the viability of cells was determined by their ability to exclude trypan blue dye.
Cells were set into agar cultures, as described previously (Hug et al., 1984) . Upper layers consisted of a mixture of aminimal essential medium (GIBCO, Grand Island, NY) and 15% FBS, in 0.3% agar (Bactoagar Difco, American Scientific Products, Houston, TX). Cells (5 x 105) were added to each 1 ml volume of this mixture. Underlayers consisted of 90% F12 and 10% horse serum (KC Biological, Lenexa, KS) in 0.5% agar. Oestradiol (5 xl0-M 17-fl-), lOpgmlinsulin, 50ng ml-1 epidermal growth factor, and 2.5,ug ml 1 hydrocortisone were supplemented to the underlayers of half of the cultures. (Each hormone was used at the dose that had maximally stimulated the clonogenic growth of 4 breast tumour cell lines (Hug et al., 1984) .) Cultures were set up in triplicate. One plate of each specimen was fixed with glutaraldehyde and stored at 40 C. Cultures were incubated at 370C in a humidified atmosphere of 5% CO2 and 12% 02 for 14 days. Cultures were then examined with an inverted phase microscope for clonogenic growth. Aggregates of 50 or more cells, or aggregates of a minimal diameter of .75pm and of uniform morphology, were considered to represent the progeny of clonogenic cells and were counted as colonies. The glutaraldehyde fixed plates were scored using the identical criteria, and the number of clumps that had contaminated the cultures were so enumerated and subtracted from the score of the cultured plates to arrive at the final colony count. The morphology of some cultured cells was also studied. Nucleolar antigens were present in all cells examined, and mucin was secreted by some. Colonies of some cultures were also transferred into tissue culture flasks, and continued outgrowth at the colony margins could at times be observed.
Clonogenicity of tumours was defined as the percentage of cells seeded that formed colonies. The hormone sensitivity of tumours was calculated as the ratio of colonies formed under hormone-supplemented and regular conditions, and was expressed at the loglo basis. For the analysis, tumours were grouped according to the disease stage as normal breast tissues (Group A), primary tumours (Group B), metastatic ER-positive tumours (Group C), metastatic ER-negative and ER-unknown tumours (Group D). Tumours that formed less than 1 colony under regular conditions were not included in our evaluation. The one-way analysis of variance with the Student-Newman Keuls multiple range test was applied to compare the clonogenic growth of tissues from the 4 groups and to compare the hormonal responsiveness of the 4 classes of tissues.
The mean viability of cells set into culture was 91 (± 8)% for all tissues of origin. There was a continuing progression of increasing clonogenicity from benign tissue through primary carcinoma to metastasis. The median number of colonies formed per 105 cells was: 4(2-19) for benign tissues, 35 (1-658) for primary carcinomas and, 74 (2-1037) for metastatic carcinoma; the respective mean values were 7+7, 90±+162, 125±+158.
Oestradiol (17-fl-), epidermal growth factor, insulin and hydrocortisone in combination were used to measure the sensitivity of cells to regular growth factors and hormones. The combined hormones increased the clonogenic cell fraction of 85 of the 92 breast tissues (92%). An increase of the clonogenic cell fraction was observed in all benign tissues, in 76% of primary tumours, and 97% of metastatic tumours. The hormones increased the clonogenicity of normal bone marrow 1.3-fold. In contrast, the hormoneinduced growth increment of breast tissues was 3.4-fold on average. The growth increment was similar for all groups of tissues, but was 4.4-fold for the metastatic ER-positive tumours. The enhanced proliferative response to hormones of ER-positive tumours was, however, not statistically significant at the 0.05 level. The hormonal sensitivity of clonogenic cells from benign and malignant tissues is summarized in Table I and illustrated in Figure 1 . Clonogenic growth of normal breast tissue in agar culture was scant. The ability of cells to form colonies developed after tissue transformation had occurred and increased further as tumours progressed from the early to the advanced stages. Since anchorage-independent growth is a criterion of transformed tissues, and clonogenicity of tumours is associated with tumour formation in mice (Shin et al., 1979) and with survival of patients , our findings are not novel. The findings support, however, the validity of the tool used to investigate some growthregulatory mechanisms of breast tumours.
Oestradiol (17-fl-), insulin, hydrocortisone, and epidermal growth factor, are among the factors and hormones that are operative in the development and growth of the mammary gland. These factors, in combination, increased the proliferative activity of all benign breast tissues, and to our surprise also of 99% of malignant breast tissues. Thus, the responsiveness of cells to these regular growth factors persisted after tissue transformation had occurred, and remained unchanged for the responsive proportion of clonogenic cells as tumours progressed from the primary to the metastatic stage. The responsiveness of the metastatic tumours that contained cytoplasmic receptors for oestrogens was even higher than that of normal breast tissues, albeit not at a statistically significant level. We conclude that two distinctive biological properties of breast tissue cells can be measured in vitro: firstly, the ability of cells to form colonies in agar cultures, and secondly, the responsiveness of these clonogenic cells to factors that can regulate their proliferative activity. We found that the clonogenicity of tissues increased with the formation of tumours and with the progression of tumours to the more advanced stages, while the responsiveness of clonogenic cells to some of the hormones that regulate the development of the parent organ tissue persisted for a large proportion of tumours. Although autocrine and paracrine growth factors are often considered more important growth regulators of tumours (Rozengurt, 1983; Todaro et al., 1980; Sirbasku, 1978; Sporn & Todaro, 1980) regular and tumour-specific growth factors, and to define if these factors act independently or in concert. It is of note, however, that in a small sample of patients the response to endocrine treatment was associated with the in vitro responsiveness of their tumour to these regular hormones Ro et al., 1985) .
